UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Development and Function of the Human Fetal Adrenal Cortex: A Key Component in the Feto-Placental Unit

Endocrine reviews, 2011-06, Vol.32 (3), p.317-355

2011

Link zum Volltext

Verfügbarkeit prüfen

Biological Roles of the Delta Family Notch Ligand Dll4 in Tumor and Endothelial Cells in Ovarian Cancer

Cancer research (Chicago, Ill.), 2011-09, Vol.71 (18), p.6030-6039

2011

Link zum Volltext

Verfügbarkeit prüfen

Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma

Cancer research (Chicago, Ill.), 2007-02, Vol.67 (4), p.1757-1768

2007

Link zum Volltext

Verfügbarkeit prüfen

Role of vascular endothelial growth factor in ovarian physiology and pathology

Fertility and sterility, 2000-09, Vol.74 (3), p.429-438

2000

Link zum Volltext

Verfügbarkeit prüfen

Vascular Endothelial Growth Factor-Trap Decreases Tumor Burden, Inhibits Ascites, and Causes Dramatic Vascular Remodeling in an Ovarian Cancer Model

Clinical cancer research, 2003-11, Vol.9 (15), p.5721-5728

2003

Link zum Volltext

Verfügbarkeit prüfen

Vascular Endothelial Growth Factor Trap Combined with Paclitaxel Strikingly Inhibits Tumor and Ascites, Prolonging Survival in a Human Ovarian Cancer Model

Clinical cancer research, 2005-10, Vol.11 (19), p.6966-6971

2005

Link zum Volltext

Verfügbarkeit prüfen

Human Placental Vascular Development: Vasculogenic and Angiogenic (Branching and Nonbranching) Transformation Is Regulated by Vascular Endothelial Growth Factor-A, Angiopoietin-1, and Angiopoietin-2

The journal of clinical endocrinology and metabolism, 2002-09, Vol.87 (9), p.4213-4224

2002

Link zum Volltext

Verfügbarkeit prüfen

Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer

Cancer research (Chicago, Ill.), 2007, Vol.67 (1), p.281-288

2007

Link zum Volltext

Verfügbarkeit prüfen

Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models

Cancer biology & therapy, 2010-02, Vol.9 (3), p.176-182

2010

Link zum Volltext

Verfügbarkeit prüfen

Phosphatidylinostol 3-Kinase Mediates Angiogenesis and Vascular Permeability Associated with Ovarian Carcinoma

Clinical cancer research, 2005-11, Vol.11 (22), p.8208-8212

2005

Link zum Volltext

Verfügbarkeit prüfen

Vascular Endothelial Growth Factor Immunoneutralization Plus Paclitaxel Markedly Reduces Tumor Burden and Ascites in Athymic Mouse Model of Ovarian Cancer

The American journal of pathology, 2002-11, Vol.161 (5), p.1917-1924

2002

Link zum Volltext

Verfügbarkeit prüfen

Dual Targeting of Endothelial Cells and Pericytes in Antivascular Therapy for Ovarian Carcinoma

Clinical cancer research, 2007-07, Vol.13 (14), p.4209-4217

2007

Link zum Volltext

Verfügbarkeit prüfen

Impact of vessel maturation on antiangiogenic therapy in ovarian cancer

American journal of obstetrics and gynecology, 2008-04, Vol.198 (4), p.477.e1-477.e10

2008

Link zum Volltext

Verfügbarkeit prüfen

Tissue Distribution of Estrogen Receptors Alpha (ER-α) and Beta (ER-β) mRNA in the Midgestational Human Fetus

The journal of clinical endocrinology and metabolism, 1997-10, Vol.82 (10), p.3509-3512

1997

Link zum Volltext

Verfügbarkeit prüfen

Anti-angiogenic properties of metronomic topotecan in ovarian carcinoma

Cancer biology & therapy, 2009-08, Vol.8 (16), p.1596-1603

2009

Link zum Volltext

Verfügbarkeit prüfen

The role of alendronate in mitigating perimenopausal bone loss: a double-blind randomized controlled pilot study

Fertility and sterility, 2010-08, Vol.94 (3), p.1138-1140

2010

Link zum Volltext

Verfügbarkeit prüfen

A challenge for the 21st century: whither physician-scientists in obstetrics, gynecology, and the reproductive sciences?

American journal of obstetrics and gynecology, 2008-05, Vol.198 (5), p.489-495

2008

Link zum Volltext

Verfügbarkeit prüfen

In Memoriam: Pentti K. Siiteri, Ph.D. Editor-in-Chief, Endocrine Reviews, 1985–1990

Endocrine reviews, 2012-08, Vol.33 (4), p.503-503

Jaffe, Robert B

2012

Link zum Volltext

Verfügbarkeit prüfen

Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth

Molecular cancer therapeutics, 2016-06, Vol.15 (6), p.1344-1352

2016

Link zum Volltext

Verfügbarkeit prüfen

Selective Estrogen Receptor Modulators: An Update on Recent Clinical Findings

Obstetrical & gynecological survey, 2008-03, Vol.63 (3), p.163-181

2008

Link zum Volltext

Verfügbarkeit prüfen

Selective Estrogen Receptor Modulators: An Update on Recent Clinical Findings

Obstetrical & gynecological survey, 2008-03, Vol.63 (3), p.163-181

2008

Link zum Volltext

Verfügbarkeit prüfen

Role of Vascular Endothelial Growth Factor in Ovarian Cancer : Inhibition of Ascites Formation by Immunoneutralization

The American journal of pathology, 1998-10, Vol.153 (4), p.1249-1256

1998

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models

Cancer research (Chicago, Ill.), 2002-02, Vol.62 (4), p.1087-1092

2002

Link zum Volltext

Verfügbarkeit prüfen

Management of Postmenopausal Hot Flushes With Venlafaxine Hydrochloride: A Randomized, Controlled Trial

Obstetrics and gynecology (New York. 1953), 2005-01, Vol.105 (1), p.161-166

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 689

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(632)
Mit Volltextzugriff
(611)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(429)
Humans
(400)
Life Sciences & Biomedicine
(397)
Female
(295)
Biological And Medical Sciences
(184)
Male
(157)
Adult
(131)
Medical Sciences
(123)
Endocrinology & Metabolism
(95)
Animals
(94)
Middle Aged
(84)
Fundamental And Applied Biological Sciences. Psychology
(71)
Pregnancy
(70)
Obstetrics & Gynecology
(56)
Adolescent
(54)
Aged
(50)
Child
(40)
Oncology
(40)
Luteinizing Hormone - Blood
(38)
Time Factors
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Development and Function of the Human Fetal Adrenal Cortex: A Key Component in the Feto-Placental Unit

Biological Roles of the Delta Family Notch Ligand Dll4 in Tumor and Endothelial Cells in Ovarian Cancer

Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma

Role of vascular endothelial growth factor in ovarian physiology and pathology

Vascular Endothelial Growth Factor-Trap Decreases Tumor Burden, Inhibits Ascites, and Causes Dramatic Vascular Remodeling in an Ovarian Cancer Model

Vascular Endothelial Growth Factor Trap Combined with Paclitaxel Strikingly Inhibits Tumor and Ascites, Prolonging Survival in a Human Ovarian Cancer Model

Human Placental Vascular Development: Vasculogenic and Angiogenic (Branching and Nonbranching) Transformation Is Regulated by Vascular Endothelial Growth Factor-A, Angiopoietin-1, and Angiopoietin-2

Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer

Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models

Phosphatidylinostol 3-Kinase Mediates Angiogenesis and Vascular Permeability Associated with Ovarian Carcinoma

Vascular Endothelial Growth Factor Immunoneutralization Plus Paclitaxel Markedly Reduces Tumor Burden and Ascites in Athymic Mouse Model of Ovarian Cancer

Dual Targeting of Endothelial Cells and Pericytes in Antivascular Therapy for Ovarian Carcinoma

Impact of vessel maturation on antiangiogenic therapy in ovarian cancer

Tissue Distribution of Estrogen Receptors Alpha (ER-α) and Beta (ER-β) mRNA in the Midgestational Human Fetus

Regulation of Tumor Angiogenesis by EZH2

Anti-angiogenic properties of metronomic topotecan in ovarian carcinoma

The role of alendronate in mitigating perimenopausal bone loss: a double-blind randomized controlled pilot study

A challenge for the 21st century: whither physician-scientists in obstetrics, gynecology, and the reproductive sciences?

In Memoriam: Pentti K. Siiteri, Ph.D. Editor-in-Chief, Endocrine Reviews, 1985–1990

Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth

Selective Estrogen Receptor Modulators: An Update on Recent Clinical Findings

Selective Estrogen Receptor Modulators: An Update on Recent Clinical Findings

Role of Vascular Endothelial Growth Factor in Ovarian Cancer : Inhibition of Ascites Formation by Immunoneutralization

Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models

Management of Postmenopausal Hot Flushes With Venlafaxine Hydrochloride: A Randomized, Controlled Trial

Suchergebnisse filtern